Log in

The global pharmaceutical market remained dynamic in 2016

Despite the trend to regulate drug prices, the global pharmaceutical market continued to grow strongly last year and should remain well-oriented by 2020, according to a study by QuintilesIMS published Friday.

Global drug sales increased by 7% in 2016, reaching 1.085 billion. And they should grow from 4% to 7% per year on average by 2020, driven by the US in value terms and by emerging countries in volume, according to the study.

China became the world's second largest pharmaceutical market last year, behind the United States, thanks to its consumption of generics.

However, the Japanese market remains the world's second-largest provider of patent-protected medicines, according to Stéphane Sclison, chief strategy officer at QuintilesIMS, said in a statement.

Sales in North America, which accounts for nearly half of the global pharmaceutical market, increased by 6% last year, as in the Africa-Asia-Pacific area (24% of the world market).

In Europe (22% of the world market), drug sales increased by 5% last year, but are expected to return to "more moderate" levels in the coming years, according to QuintilesIMS, notably because the impact of The arrival of innovative and expensive drugs against hepatitis C, which had spurred spending, has been stabilized.

In France, the city market (medicines sold in pharmacies), in decline since 2010, continued to decline last year (-0,4% to 19,47 billion), mainly due to government-imposed price cuts On reimbursed drugs, according to the research firm.

a3p-100pxhaut logo


Commit to share
Transmit and progress together
Promoting innovation

The A3P Association is a major player in the pharmaceutical and biotechnology industry.
Created in 1986, it contributes to the good development of the production of medicines and clean and sterile equipment, it runs a network of professionals 21 000, manufacturers and suppliers, as part of International Congress and technical days.

It now has over 1700 members who share their technical experience, scientific and regulatory.

More info on video (Versiongb here )

  group    administrators A3P
& Project Managers

letter   newsletter A3P